Is CRISPR Therapeutics a Millionaire Maker? [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
But could this biotech's halcyon days be so good that a $10,000 investment today could end up being worth millions of dollars? Although such returns may seem wild, history is full of many such wealth-generating events. Let's dive in and explore if investors can bank on CRISPR Therapeutics stock to generate ground-breaking returns. The outlook is positive, and it could get even better If CRISPR Therapeutics is going to experience dramatic growth, the road to becoming a millionaire will be called Casgevy. Casgevy, the biotech's first medicine to be approved for sale, is a gene therapy that treats -- or effectively cures -- a pair of hereditary blood diseases, sickle cell disease (SCD), and transfusion-dependent beta thalassemia (TDT). Since the U.S. Food and Drug Administration (FDA) granted approvals for both indications only in December 2023 and January 2024, respectively, the therapy hasn't had enough time to generate a full quarter's worth of revenue data. However, it's a g
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapies Market Research 2024: Pipeline Analysis, Therapeutic Assessment, Unmet Needs, Impact of Drugs [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis) [Seeking Alpha]Seeking Alpha
- Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought [Yahoo! Finance]Yahoo! Finance
- Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report? [Yahoo! Finance Canada]Yahoo! Finance Canada
CRSP
Earnings
- 5/9/24 - Beat
CRSP
Sec Filings
- 6/3/24 - Form 8-K
- 5/31/24 - Form 4
- 5/31/24 - Form 4
- CRSP's page on the SEC website